FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024727509> ?p ?o ?g. }

• W2024727509 endingPage "1188" @default.
• W2024727509 startingPage "1179" @default.
• W2024727509 abstract "In experimental models of glioblastoma multiforme (GBM), irradiation (IR) induces local expression of the chemokine CXCL12/SDF-1, which promotes tumour recurrence. The role of CXCR7, the high-affinity receptor for CXCL12, in the tumour's response to IR has not been addressed.We tested CXCR7 inhibitors for their effects on tumour growth and/or animal survival post IR in three rodent GBM models. We used immunohistochemistry to determine where CXCR7 protein is expressed in the tumours and in human GBM samples. We used neurosphere formation assays with human GBM xenografts to determine whether CXCR7 is required for cancer stem cell (CSC) activity in vitro.CXCR7 was detected on tumour cells and/or tumour-associated vasculature in the rodent models and in human GBM. In human GBM, CXCR7 expression increased with glioma grade and was spatially associated with CXCL12 and CXCL11/I-TAC. In the rodent GBM models, pharmacological inhibition of CXCR7 post IR caused tumour regression, blocked tumour recurrence, and/or substantially prolonged survival. CXCR7 expression levels on human GBM xenograft cells correlated with neurosphere-forming activity, and a CXCR7 inhibitor blocked sphere formation by sorted CSCs.These results indicate that CXCR7 inhibitors could block GBM tumour recurrence after IR, perhaps by interfering with CSCs." @default.
• W2024727509 created "2016-06-24" @default.
• W2024727509 creator A5002890512 @default.
• W2024727509 creator A5004589257 @default.
• W2024727509 creator A5004784274 @default.
• W2024727509 creator A5005565354 @default.
• W2024727509 creator A5008830078 @default.
• W2024727509 creator A5011927363 @default.
• W2024727509 creator A5016145140 @default.
• W2024727509 creator A5024194897 @default.
• W2024727509 creator A5024443234 @default.
• W2024727509 creator A5028477303 @default.
• W2024727509 creator A5028862628 @default.
• W2024727509 creator A5030160008 @default.
• W2024727509 creator A5034732141 @default.
• W2024727509 creator A5034768472 @default.
• W2024727509 creator A5039706503 @default.
• W2024727509 creator A5052061341 @default.
• W2024727509 creator A5071494723 @default.
• W2024727509 creator A5078844354 @default.
• W2024727509 creator A5079966273 @default.
• W2024727509 creator A5081896291 @default.
• W2024727509 creator A5082488310 @default.
• W2024727509 creator A5086973856 @default.
• W2024727509 date "2014-01-14" @default.
• W2024727509 modified "2023-10-06" @default.
• W2024727509 title "Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats" @default.
• W2024727509 cites W1979222618 @default.
• W2024727509 cites W1980275866 @default.
• W2024727509 cites W1983805959 @default.
• W2024727509 cites W1991354341 @default.
• W2024727509 cites W1997848361 @default.
• W2024727509 cites W1999392449 @default.
• W2024727509 cites W2001009247 @default.
• W2024727509 cites W2001544973 @default.
• W2024727509 cites W2007534966 @default.
• W2024727509 cites W2010364386 @default.
• W2024727509 cites W2010436322 @default.
• W2024727509 cites W2015749045 @default.
• W2024727509 cites W2029470215 @default.
• W2024727509 cites W2038937310 @default.
• W2024727509 cites W2039075677 @default.
• W2024727509 cites W2040776944 @default.
• W2024727509 cites W2041561496 @default.
• W2024727509 cites W2042723035 @default.
• W2024727509 cites W2046220184 @default.
• W2024727509 cites W2050568971 @default.
• W2024727509 cites W2050605813 @default.
• W2024727509 cites W2051588629 @default.
• W2024727509 cites W2053704719 @default.
• W2024727509 cites W2054792114 @default.
• W2024727509 cites W2059234310 @default.
• W2024727509 cites W2060551076 @default.
• W2024727509 cites W2071575257 @default.
• W2024727509 cites W2077021879 @default.
• W2024727509 cites W2082075729 @default.
• W2024727509 cites W2083910421 @default.
• W2024727509 cites W2088454377 @default.
• W2024727509 cites W2089260704 @default.
• W2024727509 cites W2112703519 @default.
• W2024727509 cites W2115785123 @default.
• W2024727509 cites W2123792735 @default.
• W2024727509 cites W2124078079 @default.
• W2024727509 cites W2129289878 @default.
• W2024727509 cites W2143580838 @default.
• W2024727509 cites W2154218549 @default.
• W2024727509 cites W2156174772 @default.
• W2024727509 cites W2157695778 @default.
• W2024727509 cites W2161632137 @default.
• W2024727509 cites W2161766823 @default.
• W2024727509 cites W2164204972 @default.
• W2024727509 cites W2164578622 @default.
• W2024727509 cites W2165730964 @default.
• W2024727509 cites W2166592301 @default.
• W2024727509 cites W2167414381 @default.
• W2024727509 cites W2171581347 @default.
• W2024727509 doi "https://doi.org/10.1038/bjc.2013.830" @default.
• W2024727509 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3950859" @default.
• W2024727509 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24423923" @default.
• W2024727509 hasPublicationYear "2014" @default.
• W2024727509 type Work @default.
• W2024727509 sameAs 2024727509 @default.
• W2024727509 citedByCount "70" @default.
• W2024727509 countsByYear W20247275092014 @default.
• W2024727509 countsByYear W20247275092015 @default.
• W2024727509 countsByYear W20247275092016 @default.
• W2024727509 countsByYear W20247275092017 @default.
• W2024727509 countsByYear W20247275092018 @default.
• W2024727509 countsByYear W20247275092019 @default.
• W2024727509 countsByYear W20247275092020 @default.
• W2024727509 countsByYear W20247275092021 @default.
• W2024727509 countsByYear W20247275092022 @default.
• W2024727509 countsByYear W20247275092023 @default.
• W2024727509 crossrefType "journal-article" @default.
• W2024727509 hasAuthorship W2024727509A5002890512 @default.
• W2024727509 hasAuthorship W2024727509A5004589257 @default.
• W2024727509 hasAuthorship W2024727509A5004784274 @default.
• W2024727509 hasAuthorship W2024727509A5005565354 @default.

• next